|

|

| U.S. Nuclear
Power Reactor Map
iOSAT™
received its approval from the US Food and Drug Administration in 1982,
and is the only full-strength tablet for radiation blocking which may
legally be sold in the US. Only iOSAT™ has passed all FDA tests for purity, quality, safety and efficacy.
Meets all FDA requirements
for potassium iodide as a radiation protective, and is labeled and packaged
in accordance with US government guidelines.
Has demonstrated all quality controls and passed all FDA requirements
for purity, quality, safety, efficacy.
Comes full strength (130
mg of potassium iodide per tablet) in accordance with FDA demands for complete
thyroid blocking.
|
|
|
|
Summary
iOSAT™
is the first radiation protective tablet available to the general
public. Experts agree that its prompt use would be the most effective
measure available to protect millions of people who would be at risk in
a nuclear accident or under a radiation threat from a terrorist nuclear
weapon. These FDA approved tablets contain potassium iodide (KI) which
provides virtually complete protection from radioactive iodine [ RAI ],
the contaminant that causes thyroid cancer. Should RAI ever
escape, the health effects would be disastrous.
It has already happened. RAI released from the 1986 Chernobyl nuclear
accident spread throughout Europe for hundreds of miles. According to
the United Nations International Thyroid Project, this led to over
11,000 cases of children's thyroid cancer by the year 2000, with more
expected to occur before the disease peaks in about 2010.
But investigators, including the UN, the World Health Organization
(WHO), the US FDA, the US Nuclear Regulatory Commission (NRC) and The
American Thyroid Association, uncovered the following unexpected
findings at Chernobyl:
- Thyroid cancer was the only prominent health problem
to effect the general population. Although the accident released many
types of radioactive isotopes to the environment, all of the injuries
(to people located more than a few miles from the reactor) were limited
to just the effects of radioactive iodine. As the NRC and WHO have
reported,
|
"except
for thyroid cancer, there has been no confirmed increase in the rates
of other cancers, including leukemia ... attributed to releases from
the accident. In addition, there is no evidence of any excess
hereditary disease in children born after the accident." |
In other words, the use of iOSAT™ can safeguard people from most of the danger of a nuclear accident.
- The accident was not local. Within five years of the accident,
children's thyroid cancer began appearing throughout Europe. According
to the NRC,
|
"the vast majority of the cancers were diagnosed among those living more than 50 km (31 miles) from the site." |
Others reported identical findings, with the WHO noting,
|
"the
increase has been documented up to 500 km from the accident site, [and
that] significant doses can occur hundreds of kilometers beyond
emergency planning zones." |
At the time of the Chernobyl accident, Soviet authorities immediately
distributed large amounts of potassium iodide to people living within
30 miles around the plant in order to neutralize the radiation. This
protection was effective. As shown below, only 3% of the first 750
recorded cancers took place near the Chernobyl reactor. But farther
away (beyond 30 miles) almost no KI was available, and children in
these areas suffered dramatically. Without KI, children's cancer rates
soared, with the vast majority (as high as 97%) of the cancer taking
place more than 30 miles from the reactor. Perhaps most disturbing was
that 17% of the early cancer occurred more than 350 km (200 miles)
distant. In Poland, the government distributed previously stockpiled KI
to nearly every child, with the result that Poland, alone among the
countries in the area, suffered no cancer due to Chernobyl.

Source: US NRC
As can be seen, in a serious accident, people hundreds of miles downwind of the site may require iOSAT™
for radiation protection. This fact raises serious questions about the
feasibility of the government's current emergency planning strategy,
which is based on the evacuation of anyone at risk. Millions of people
might have to be relocated, and how this could be achieved is not
clear. Worse, while trying to evacuate, people could be caught
outdoors, sitting in traffic, where they would be highly vulnerable to
RAI exposure and totally unprotected.


200 Mile Zones around US Power Reactors
|
|

|

| U.S. Power Reactor
Radiation Zones
Contains no potassium iodate
or other adulterants. Contains only pure potassium iodide as the active
ingredient.
IOSAT [potassium iodide]
Is manufactured in the United States under strict FDA GMP guidelines,
and
holds an approved New Drug Application (NDA).
IOSAT [potassium iodide]
Was the first product of its kind (since 1982) and is the only product that
can be purchased by local, state and federal governments.
Is widely purchased by nuclear utilities.
IOSAT [potassium iodide]
offers unit dose packaging for maximum shelf-life and allows for individual
tablet distribution without fear of loss of packaging integrity.
|
|
|